158 related articles for article (PubMed ID: 8364870)
1. DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancer.
Merkel DE; Winchester DJ; Goldschmidt RA; August CZ; Wruck DM; Rademaker AW
Cancer; 1993 Sep; 72(6):1926-32. PubMed ID: 8364870
[TBL] [Abstract][Full Text] [Related]
2. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
[TBL] [Abstract][Full Text] [Related]
3. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
4. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
Prasad AR; Divine G; Zarbo RJ
Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
[TBL] [Abstract][Full Text] [Related]
6. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
7. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189.
Simpson JF; Gray R; Dressler LG; Cobau CD; Falkson CI; Gilchrist KW; Pandya KJ; Page DL; Robert NJ
J Clin Oncol; 2000 May; 18(10):2059-69. PubMed ID: 10811671
[TBL] [Abstract][Full Text] [Related]
9. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
10. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
11. The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting.
Wong SW; Rangan AM; Bilous AM; Boyages J; Gebski V; Benson EM
Pathology; 1999 May; 31(2):90-4. PubMed ID: 10399161
[TBL] [Abstract][Full Text] [Related]
12. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
[TBL] [Abstract][Full Text] [Related]
13. S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer.
Malmström P; Bendahl PO; Boiesen P; Brünner N; Idvall I; Fernö M;
J Clin Oncol; 2001 Apr; 19(7):2010-9. PubMed ID: 11283134
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry in breast cancer: prognostic and surgical indications of the sparing of axillary lymph node dissection.
Zanon C; Durando A; Geuna M; Clara R; Mobiglia A; Massobrio M; Palestro G; Pourshayesteh A
Am J Clin Oncol; 1998 Aug; 21(4):392-7. PubMed ID: 9708640
[TBL] [Abstract][Full Text] [Related]
15. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population.
Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
Cancer; 1992 Oct; 70(7):1928-34. PubMed ID: 1525768
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and reinforcement of the correlation of S-phase fraction with nodal metastases, tumor grade and tumor size in breast carcinoma patients in Pakistan.
Bakhtawar H; Ali NM; Khan S; Aziz SA; Sliddiqui T; Pervez S
Pathol Res Pract; 2001; 197(8):531-6. PubMed ID: 11518045
[TBL] [Abstract][Full Text] [Related]
17. Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.
Ewers SB; Attewell R; Baldetorp B; Borg A; Långström E; Killander D
Breast Cancer Res Treat; 1992 Jan; 20(2):93-108. PubMed ID: 1554892
[TBL] [Abstract][Full Text] [Related]
18. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. French Federation of Cancer Centers (FNCLCC) Sarcoma Group.
Collin F; Chassevent A; Bonichon F; Bertrand G; Terrier P; Coindra JM
Cancer; 1997 Jun; 79(12):2371-9. PubMed ID: 9191525
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
